124 related articles for article (PubMed ID: 1575184)
1. Efficacy of a single dose of slow-release isosorbide dinitrate in the treatment of silent or painful myocardial ischemia in stable angina pectoris.
Dubiel JP; Moczurad KW; Bryniarski L
Am J Cardiol; 1992 May; 69(14):1156-60. PubMed ID: 1575184
[TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
Friedensohn A; Meshulam R; Schlesinger Z
Cardiology; 1991; 79 Suppl 2():31-40. PubMed ID: 1760827
[TBL] [Abstract][Full Text] [Related]
3. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate (ISDN) during acute and short-term administration in stable angina pectoris.
Wagner F; Gohlke-Bärwolf C; Trenk D; Jähnchen E; Roskamm H
Eur Heart J; 1991 Sep; 12(9):994-9. PubMed ID: 1936012
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of isosorbide-5-mononitrate on painful and silent myocardial ischemia after myocardial infarction.
Feng JZ; Feng XH; Schneeweiss A
Am J Cardiol; 1990 Jun; 65(21):32J-35J. PubMed ID: 2190460
[TBL] [Abstract][Full Text] [Related]
5. Preventive administration of intravenous N-acetylcysteine and development of tolerance to isosorbide dinitrate in patients with angina pectoris.
Boesgaard S; Aldershvile J; Poulsen HE
Circulation; 1992 Jan; 85(1):143-9. PubMed ID: 1728443
[TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind comparison of isosorbide dinitrate and nifedipine in variant angina pectoris.
Aschermann M; Bultas J; Karetová D; Kölbel F; Kozáková M; Simper D
Am J Cardiol; 1990 Jun; 65(21):46J-49J. PubMed ID: 2190462
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the efficacy of isosorbide dinitrate by captopril in stable angina pectoris.
Metelitsa VI; Martsevich SYu ; Kozyreva MP; Slastnikova ID
Am J Cardiol; 1992 Feb; 69(4):291-6. PubMed ID: 1734637
[TBL] [Abstract][Full Text] [Related]
8. Isosorbide-5-mononitrate and nifedipine can reduce ischaemic ST-segment changes during Holter monitoring in patients with spontaneous angina pectoris.
von Arnim T; Erath A; Reuschel-Janetschek E
Eur Heart J; 1988 Jan; 9 Suppl A():113-8. PubMed ID: 3409907
[TBL] [Abstract][Full Text] [Related]
9. Increased exercise tolerance and reduced duration of ischemia after isosorbide dinitrate oral spray in angina pectoris.
Marmor A; Plich M; Blondheim D; Sharir T; Alpert JS
Am J Cardiol; 1988 Mar; 61(9):4E-6E. PubMed ID: 3348139
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of isosorbide dinitrate and nitroglycerin in relieving angina pectoris during uninterrupted exercise.
Kattus AA; Alvaro AB; Coulson A
Chest; 1975 Jun; 67(6):640-6. PubMed ID: 805037
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
12. Comparison of transdermal nitrate and isosorbide dinitrate in chronic stable angina.
Nicholls DP; Moles K; Gleadhill DN; Booth K; Rowan J; Morton P
Br J Clin Pharmacol; 1986 Jul; 22(1):15-20. PubMed ID: 3091055
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris.
Krepp HP
Cardiology; 1991; 79 Suppl 2():14-8. PubMed ID: 1760823
[TBL] [Abstract][Full Text] [Related]
14. Sustained effect of and lack of development of tolerance to controlled-release isosorbide-5-mononitrate in chronic stable angina pectoris.
Wisenberg G; Roks C; Nichol P; Goddard MD
Am J Cardiol; 1989 Sep; 64(10):569-76. PubMed ID: 2782247
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
Schneider W; Maul FD; Bussmann WD; Lang E; Hör G; Kaltenbach M
Eur Heart J; 1988 Feb; 9(2):149-58. PubMed ID: 3280317
[TBL] [Abstract][Full Text] [Related]
16. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.
Thadani U; Hamilton SF; Olson E; Anderson JL; Prasad R; Voyles W; Doyle R; Kirsten E; Teague SM
Am J Cardiol; 1987 Apr; 59(8):756-62. PubMed ID: 3825935
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic effects of once-daily isosorbide-5-mononitrate on the exercise capacity of patients with angina pectoris treated with a beta-blocking drug.
Eteiba H; Hutton I; Foale RA; Akhras F; Jackson G; Prescott RJ; Hallam RJ; Quinn KJ
Br J Clin Pract; 1991; 45(3):185-8. PubMed ID: 1687200
[TBL] [Abstract][Full Text] [Related]
19. Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination.
Kawanishi DT; Reid CL; Morrison EC; Rahimtoola SH
J Am Coll Cardiol; 1992 Feb; 19(2):409-17. PubMed ID: 1732370
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.
Quyyumi AA; Crake T; Wright CM; Mockus LJ; Fox KM
Br Heart J; 1987 Jun; 57(6):505-11. PubMed ID: 3304367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
